Biogen’s potentially game-changing Alzheimer’s drug still faces an uphill battle with the FDA

"It's a complete coin flip that will now be in the hands of the FDA," says Jared Holz, a health-care strategist at Jefferies. Health and Science U.S.HEALTHCARE UPDATE: SPECIAL NEWS UPDATE: Click today to request your free ACRX discount prescription … Read more…